AcuCort AB (publ) (XSAT: ACUC)
Health Care · Pharmaceuticals · SE
Skr0.40
-19.88% today · -19.2% 1Y
AcuCort AB (publ) (XSAT: ACUC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.70M.
Over the last twelve months the share price has lost 19.2%, trading between 0.40 and 0.95.
Tweenvest scores AcuCort AB (publ) across four factors: quality 41/100, value 31/100, growth 86/100. Its strongest factor is growth.
ACUC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.70M
- Revenue (TTM)
- $173.65K
- P/E
- —
- EPS
- -0.11
- Dividend yield
- —
- Beta (5Y)
- 1.41
- 52-week high
- Skr0.95
- 52-week low
- Skr0.40
- Avg volume (3M)
- —
- Shares outstanding
- 234.44M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $— | — |
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $11.84M | ₩2,570.00 | -3.20% |
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.82M | $0.75 | -3.01% |
| Hepion Pharmaceuticals, Inc.OTCPK: HEPA | $11.79M | $0.12 | +48.15% |
| Argenica Therapeutics LimitedASX: AGN | $11.65M | AU$0.13 | -13.33% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $11.64M | $7.64 | -7.95% |
| OncoZenge AB (publ)OM: ONCOZ | $11.54M | Skr3.79 | -9.33% |
| Silva Pharmaceuticals LimitedDSE: SILVAPHL | $11.53M | Tk10.40 | -16.80% |
Figures last refreshed Oct 11, 2026.